SCNI

NASD Scinai Immunotherapeutics Ltd. Sponsored ADR
Oct 3, 2026 · 12:39 PM ET EOD Market Closed

$1.33 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.33, $0.04 below the day’s high of $1.37

YTD change
-81.32%
vs 20-day SMA
-21.37%
vs 200-day SMA
-74.38%

Price ranges

Previous day
$1.30 $1.37
open $1.30 close $1.33
+$0.03 (+2.31%)
Today
$1.30 $1.37
$1.33
Past week
$1.27 $1.86
from $1.86 now $1.33
-$0.53 (-28.49%)
Past month
$1.27 $2.67
from $2.34 now $1.33
-$1.01 (-43.16%)
This year
$0.21 $7.12
from $7.12 now $1.33
-$5.79 (-81.32%)

Price & Performance

+0.72 (+118.03%) / 6M

$-0.0111$1.15$2.30$3.46Apr 6Jul 6Oct 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 99.0% away from all-time highs of $137.00
  • SCNI is down 81% since the beginning of the year
  • SCNI is down 90% over the past 12 months
  • SCNI is down 43% over the past 1 month
  • 33% of all SCNI investors are betting against SCNI

SCNI reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +0.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-3.6618
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $7.1M
Beta 1.91

Balance sheet & scale

IncomeN/A
Revenue$1.5M
Cash$2.9M
Debt$3.6K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $1.8M

Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $403.04 -1.04%
MRNA Moderna, Inc. $190.01 +0.57%
RVMD Revolution Medicines, Inc. $206.64 +0.36%
ROIV Roivant Sciences Ltd. $35.72 +0.62%
BNTX BioNTech SE Sponsored ADR $96.90 +0.05%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.